{"log_id": 4409381052057307653, "direction": 0, "words_result_num": 48, "words_result": [{"probability": {"variance": 0.004807, "average": 0.922448, "min": 0.831542}, "location": {"width": 93, "top": 153, "height": 21, "left": 225}, "words": "药过量"}, {"probability": {"variance": 0.026553, "average": 0.893518, "min": 0.395838}, "location": {"width": 833, "top": 182, "height": 26, "left": 252}, "words": "过注射的平斑应是生的,主要影响脚部排心血管系统,治疗熏点是支持所生命功能,并及时进行对症治疗"}, {"probability": {"variance": 0.038283, "average": 0.899671, "min": 0.353434}, "location": {"width": 333, "top": 210, "height": 22, "left": 220}, "words": "佛醇与浆血清蛋结合,因此可透析"}, {"probability": {"variance": 0.022628, "average": 0.821186, "min": 0.518864}, "location": {"width": 433, "top": 240, "height": 22, "left": 251}, "words": "动物体内碘醇静脉内L门(glkg)为:小17:大"}, {"probability": {"variance": 0.0001, "average": 0.988973, "min": 0.976283}, "location": {"width": 93, "top": 269, "height": 20, "left": 223}, "words": "【药理理"}, {"probability": {"variance": 0.038555, "average": 0.809148, "min": 0.355844}, "location": {"width": 839, "top": 296, "height": 28, "left": 250}, "words": "碘佛过放射线效性的增增强描、密度增囊的程注射剂盘中的含碘盘直接橙关。因为平可能灼病点"}, {"probability": {"variance": 0.028416, "average": 0.886809, "min": 0.408883}, "location": {"width": 867, "top": 326, "height": 28, "left": 221}, "words": "是供足够的诊断资料,而造影增强作用会增训危险射线照,因此在决定使程前,应细心评估临床、其他放射性诊和平"}, {"probability": {"variance": 0.033816, "average": 0.843033, "min": 0.360471}, "location": {"width": 860, "top": 356, "height": 27, "left": 228}, "words": "结果。使连续描技术(即动态C扫)可使肿瘤和其他病变,如脓肿的显影增强,有时会显示没有怀疑到或更严重"}, {"probability": {"variance": 0.02968, "average": 0.849192, "min": 0.370784}, "location": {"width": 871, "top": 385, "height": 27, "left": 215}, "words": "射病。例如,与平扫比较,增强扫描可分辨囊血管的实质性病变;无灌注的组织显示X线吸收(T值无改变,"}, {"probability": {"variance": 0.029426, "average": 0.872308, "min": 0.41827}, "location": {"width": 860, "top": 415, "height": 25, "left": 216}, "words": "蕾病变的特征是在血管内注入影剂后几分钟约CT值增高:它可能是悲性、良性或正常组织,但不会是囊肿、血或其"}, {"probability": {"variance": 0.037916, "average": 0.85538, "min": 0.580111}, "location": {"width": 81, "top": 444, "height": 21, "left": 217}, "words": "管病变"}, {"probability": {"variance": 0.031843, "average": 0.887124, "min": 0.430676}, "location": {"width": 838, "top": 470, "height": 29, "left": 249}, "words": "在注入含碘造影剂后的16天内,于碘量估计酶PB和放射性摄入研究并不能确切反应状腺的功能。是,甲状"}, {"probability": {"variance": 0.027337, "average": 0.908134, "min": 0.437714}, "location": {"width": 772, "top": 501, "height": 26, "left": 212}, "words": "蒸功能试验并不是俄赖于量估计的,也就是说,T3的摄入和总量或游离甲农腺素(T4)的测定并不受影响"}, {"probability": {"variance": 0.003181, "average": 0.942376, "min": 0.845167}, "location": {"width": 98, "top": 529, "height": 23, "left": 244}, "words": "头都CT扫描"}, {"probability": {"variance": 0.022311, "average": 0.929212, "min": 0.352923}, "location": {"width": 841, "top": 558, "height": 26, "left": 244}, "words": "由于血脊液屏障,在增强CT头部扫描时,碘佛不聚集在正常脑部组织。正常脑部对X线吸收的增加是由"}, {"probability": {"variance": 0.019974, "average": 0.922256, "min": 0.380999}, "location": {"width": 866, "top": 587, "height": 26, "left": 210}, "words": "于在池内有造影剂。血脑脊液屏障的破坏,如发生脑部恶性瘤时造影剂聚集在瘤组织隙,邻近正常脑组织不含造影剂"}, {"probability": {"variance": 0.004606, "average": 0.969187, "min": 0.667438}, "location": {"width": 839, "top": 616, "height": 26, "left": 243}, "words": "组织内的最大造影增强作用常出现于血碘峰值后延迟也可能发生。快速静脉注射造影剂后的1小时内仍可获得用作诊"}, {"probability": {"variance": 0.015427, "average": 0.930431, "min": 0.406434}, "location": {"width": 865, "top": 645, "height": 26, "left": 209}, "words": "断的脑造影增强CT图像。这一延退的机制尚不清楚,可以说明造影增强至少部分依粒于病变处和池外含碘物质的聚集"}, {"probability": {"variance": 0.004659, "average": 0.957087, "min": 0.750559}, "location": {"width": 573, "top": 675, "height": 24, "left": 210}, "words": "非肿瘤病变如动静脉畸形和动脉瘤的造影增强,可能依赖干循血液中的碘量"}, {"probability": {"variance": 0.004796, "average": 0.970232, "min": 0.653706}, "location": {"width": 839, "top": 704, "height": 26, "left": 242}, "words": "已知或怀疑血脊液屏罩被坏的病人,使用任何造影剂都必须评估利弊。不过与离子型造影剂相比较,非离子型对"}, {"probability": {"variance": 0.000709, "average": 0.980722, "min": 0.914106}, "location": {"width": 152, "top": 734, "height": 23, "left": 208}, "words": "中枢神经的毒更小"}, {"probability": {"variance": 0.042352, "average": 0.877716, "min": 0.419787}, "location": {"width": 100, "top": 763, "height": 23, "left": 240}, "words": "体部C扫描"}, {"probability": {"variance": 0.00727, "average": 0.962575, "min": 0.592162}, "location": {"width": 843, "top": 793, "height": 24, "left": 239}, "words": "在进行造影增强CT体部扫描(非神经组织),碘佛醇从血管内快速弥散至血管外间隙。由于不存在血-脑脊液屏障,X"}, {"probability": {"variance": 0.022213, "average": 0.927658, "min": 0.402977}, "location": {"width": 869, "top": 822, "height": 23, "left": 207}, "words": "线吸收加强与血流、造剂的浓度和肿瘤润质组织报取造影剂的情况有。造影谱强作用是电于正常和不正常组织外弥散的"}, {"probability": {"variance": 0.005304, "average": 0.970034, "min": 0.718513}, "location": {"width": 337, "top": 852, "height": 21, "left": 207}, "words": "相对盖别所至,这与脑部的情况有很大的差别"}, {"probability": {"variance": 0.003039, "average": 0.975847, "min": 0.782499}, "location": {"width": 373, "top": 880, "height": 21, "left": 236}, "words": "致癌作用、诱变作用、对生育力的损伤及致作用"}, {"probability": {"variance": 0.008351, "average": 0.969715, "min": 0.490525}, "location": {"width": 734, "top": 909, "height": 22, "left": 243}, "words": "估其致掘作用的长期动物研究还未进行。但是,动物研究表明本药物无诱变作用、也不影响生育能力"}, {"probability": {"variance": 0.00469, "average": 0.979782, "min": 0.509986}, "location": {"width": 840, "top": 939, "height": 22, "left": 237}, "words": "动物致畸学研究证实,碘佛并无致畸作用。但没有在孕妇中进行充分、很好的对照性研究。尚不知道碘佛醇是否可通"}, {"probability": {"variance": 0.008333, "average": 0.96489, "min": 0.418272}, "location": {"width": 760, "top": 967, "height": 24, "left": 202}, "words": "过胎盘屏障或进入胚胎组织。低是,很多注入的造影剂似乎可被动地通过人体胎盘屏障,并进入胚胎织"}, {"probability": {"variance": 1.1e-05, "average": 0.996545, "min": 0.991916}, "location": {"width": 107, "top": 998, "height": 21, "left": 209}, "words": "【药代动力学】"}, {"probability": {"variance": 0.01158, "average": 0.958776, "min": 0.462074}, "location": {"width": 834, "top": 1026, "height": 24, "left": 242}, "words": "红管内给药的正常受验者的碘佛醇药物动力学属于一个开放、两室模式,按一级动力学排除(快速的药物分布a期和较"}, {"probability": {"variance": 0.01255, "average": 0.936358, "min": 0.476839}, "location": {"width": 875, "top": 1054, "height": 27, "left": 200}, "words": "缓的药物排除β期)。根据12位志愿受验者的血液廓清曲线(6人接受5ml、6人接受150ml本品)显示:两种剂量的生物"}, {"probability": {"variance": 0.011531, "average": 0.957966, "min": 0.510046}, "location": {"width": 466, "top": 1086, "height": 22, "left": 202}, "words": "半衰期均为1.5小时,并无证据显示不同的剂量有不同的排泄率"}, {"probability": {"variance": 0.024832, "average": 0.915669, "min": 0.35049}, "location": {"width": 861, "top": 1114, "height": 32, "left": 231}, "words": "经血管注入后,佛主要通过肾排泄。有肾脏功能障碍的病人的排泄半衰期会延长,无肾功能异常时,使用0m"}, {"probability": {"variance": 0.000813, "average": 0.987044, "min": 0.80549}, "location": {"width": 775, "top": 1144, "height": 22, "left": 202}, "words": "剂量后的平均尿排泄半衰期为118分钟(105156),使用150ml剂量后的平均尿排泄半衰期为105分钟(7"}, {"probability": {"variance": 0.0048, "average": 0.973825, "min": 0.611656}, "location": {"width": 645, "top": 1172, "height": 24, "left": 199}, "words": "后,2小时后尿中药物浓度达峰值,24小时后排泄超过95%的注射剂。粪便排除可忽略"}, {"probability": {"variance": 0.015243, "average": 0.949252, "min": 0.487854}, "location": {"width": 595, "top": 1203, "height": 21, "left": 231}, "words": "濮佛醇没有明显地与血清或血浆蛋白结合,无明显的代谢、去离子作用或生物转化"}, {"probability": {"variance": 0.011132, "average": 0.948676, "min": 0.582936}, "location": {"width": 598, "top": 1232, "height": 21, "left": 231}, "words": "碘佛醇可能通过简单扩散越过胎盘屏障。尚不知碘佛醇分泌到乳注中达到何种租度"}, {"probability": {"variance": 0.006068, "average": 0.977049, "min": 0.479666}, "location": {"width": 823, "top": 1260, "height": 24, "left": 231}, "words": "经血管注入碘佛醇后,造影剂流经的血管将变成不透光,内部组织从可在X线上显影,直至发生明显的血液稀释"}, {"probability": {"variance": 0.011373, "average": 0.954822, "min": 0.55284}, "location": {"width": 845, "top": 1291, "height": 24, "left": 228}, "words": "碘佛醇在快速静脉注入的30~60秒内可在肾实质内显影,在肾功能正常时肾和肾盖在1~3分钟内显影,最佳对比"}, {"probability": {"variance": 2.7e-05, "average": 0.996682, "min": 0.982162}, "location": {"width": 152, "top": 1320, "height": 22, "left": 196}, "words": "在5~15分钟内产生"}, {"probability": {"variance": 0.004832, "average": 0.969118, "min": 0.741391}, "location": {"width": 572, "top": 1351, "height": 23, "left": 229}, "words": "动物实验显示碘佛醇不能通过血脑脊液屏障,且不会引起任何明显的上皮损伤"}, {"probability": {"variance": 0.008605, "average": 0.9568, "min": 0.598156}, "location": {"width": 844, "top": 1381, "height": 23, "left": 228}, "words": "碘醇通过放射线有效性的增加而增强CT翻描。密度增强的程度与注射剂量中的含碘量直接相关。快速静脉注入后便"}, {"probability": {"variance": 0.013691, "average": 0.955765, "min": 0.441187}, "location": {"width": 875, "top": 1410, "height": 23, "left": 196}, "words": "立即达到血内碘质峰值,其后5至10分钟内快速回落,血管间隔的半衰期大约为20分钟。这是由于血管内外液体隔间的"}, {"probability": {"variance": 0.005559, "average": 0.968519, "min": 0.635775}, "location": {"width": 764, "top": 1440, "height": 22, "left": 194}, "words": "稀释引起血浆浓度最初的快速回落而造成的。大约10分钟可达到与细外间隔的平衡,此后以指数级回"}, {"probability": {"variance": 0.011038, "average": 0.960148, "min": 0.406656}, "location": {"width": 837, "top": 1468, "height": 22, "left": 226}, "words": "碘醇的药物动力学在正常和异常组织中都是可变化不定的。造影增强作用在弹丸式注射后(15至120秒)达到峰值"}, {"probability": {"variance": 0.006465, "average": 0.979467, "min": 0.447568}, "location": {"width": 757, "top": 1494, "height": 23, "left": 194}, "words": "此,最大增强作用可在注射后30至90秒内的一系统连续两至三秒的扫描(即动态CT扫描)中观察到"}, {"probability": {"variance": 0.017411, "average": 0.880003, "min": 0.679241}, "location": {"width": 94, "top": 1522, "height": 21, "left": 197}, "words": "【史藏】"}], "language": 3}